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Abstract
Aims/hypothesis Lowmitochondrial activity in adipose tissue is
suggested to be an underlying factor in obesity and its metabolic
complications.We aimed to find out whethermitochondrial mea-
sures are downregulated in obesity also in isolated adipocytes.
Methods We studied young adult monozygotic (MZ) twin
pairs discordant (n=14, intrapair difference ΔBMI≥3 kg/m2)
and concordant (n=5, ΔBMI<3 kg/m2) for BMI, identified
from ten birth cohorts of 22- to 36-year-old Finnish twins.
Abdominal body fat distribution (MRI), liver fat content (mag-
netic resonance spectroscopy), insulin sensitivity (OGTT),
high-sensitivity C-reactive protein, serum lipids and adipokines
were measured. Subcutaneous abdominal adipose tissue biop-
sies were obtained to analyse the transcriptomics patterns of the
isolated adipocytes as well as of the whole adipose tissue.
Mitochondrial DNA transcript levels in adipocytes were mea-
sured by quantitative real-time PCR.Western blots of oxidative
phosphorylation (OXPHOS) protein levels in adipocytes were
performed in obese and lean unrelated individuals.
Results The heavier (BMI 29.9±1.0 kg/m2) co-twins of the
discordant twin pairs had more subcutaneous, intra-abdominal
and liver fat and were more insulin resistant (p<0.01 for all
measures) than the lighter (24.1 ± 0.9 kg/m2) co-twins.
Altogether, 2538 genes in adipocytes and 2135 in adipose tissue
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were significantly differentially expressed (nominal p<0.05) be-
tween the co-twins. Pathway analysis of these transcripts in both
isolated adipocytes and adipose tissue revealed that the heavier
co-twins displayed reduced expression of genes relating to mi-
tochondrial pathways, a result that was replicated when
analysing the pathways behind the most consistently downregu-
lated genes in the heavier co-twins (in at least 12 out of 14 pairs).
Consistently upregulated genes in adipocytes were related to
inflammation. We confirmed that mitochondrial DNA transcript
levels (12S RNA, 16SRNA,COX1,ND5,CYTB), expression of
mitochondrial ribosomal protein transcripts and a major mito-
chondrial regulator PGC-1α (also known as PPARGC1A) were
reduced in the heavier co-twins’ adipocytes (p<0.05). OXPHOS
protein levels of complexes I and III in adipocytes were lower in
obese than in lean individuals.
Conclusions/interpretation Subcutaneous abdominal adipo-
cytes in obesity show global expressional downregulation of
oxidative pathways, mitochondrial transcripts and OXPHOS
protein levels and upregulation of inflammatory pathways.
Data availability The datasets analysed and generated during
the current study are available in the figshare repository,
https://dx.doi.org/10.6084/m9.figshare.3806286.v1
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Introduction
Adipose tissue is the most flexible organ of the body,
readi ly adapt ing to changes in energy supply.
Mitochondria are essential in these adaptations, as their
molecular machinery governs the metabolic pathways by
which nutrients are either oxidised or stored [1]. The mi-
tochondria’s own genome [2] and over 1500 genes from
the nucleus [3] control the function and the energy adap-
tations of the mitochondria. Low mitochondrial biogenesis
has previously been suggested to characterise adipose tis-
sue in morbid obesity [4], insulin resistance [5] and type 2
diabetes [6], although evidence of this in healthy obesity
has been lacking. In our recent study, we demonstrated
that mitochondria-related transcripts and pathways, mito-
chondrial DNA (mtDNA) amount, mtDNA-encoded tran-
scripts and oxidative phosphorylation (OXPHOS) protein
levels are reduced in adipose tissue of obese vs lean
monozygotic (MZ) co-twins [7]. In addition, mitochondrial
content measured by mtDNA copy-number [8, 9] and
OXPHOS transcripts [9, 10] have been shown to be down-
regulated in adipose tissue in obesity, and basal oxygen
consumption is lower in adipose tissue of obese compared
with lean individuals [11].
However, since adipose tissue is a mixture of adipocytes
and stromal vascular fraction cells (SVFCs), the sole contri-
bution of adipocytes to the dysfunction of mitochondria in the
tissue is not yet known. While comparative data for adipo-
cytes and whole adipose tissue are lacking, a few previous
studies have examined mitochondrial variables in either ma-
ture adipocytes [12, 13] or pre-adipocytes [14] in obesity. Pre-
adipocytes differentiated in vitro from human subcutaneous
adipose tissue (SAT) of obese persons had lower oxygen con-
sumption rates after β-adrenergic stimulation compared with
that from lean individuals [14]. A recent study suggests that
both mitochondrial oxygen consumption rates and mitochon-
drial content are reduced in adipocytes in obesity, independent
of adipocyte size [13]. Another study proposes that the re-
duced oxidative capacity of adipocyte mitochondria in obesity
is related to overall adiposity rather than cell size [12].
However, based on data from unrelated obese and lean
groups, the genetic and acquired effects on mitochondrial
function cannot be distinguished. Further, the mitochondrial
transcriptomics pathways and their relationships with whole-
body metabolism have not been studied before in adipocytes
in obesity.
We set out to study the effects of acquired obesity on
transcriptomics profiles of adipocytes, with a specific fo-
cus on mitochondria, in a rare sample of MZ twin pairs
discordant for BMI. This design controls for genes, sex,
age and early environmental factors between obese and
lean individuals by comparing heavier and lighter co-
twins within BMI-discordant pairs. In addition to nuclear
transcriptomics pathways targeting mitochondria in both
adipocytes and adipose tissue, we measured transcript
levels of genes encoded by mtDNA and OXPHOS protein
levels in adipocytes.
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Methods
Participants
The participants were from two population-based birth cohorts
of Finnish twins: 1975–1979 (FinnTwin16, n=2839 pairs) and
1983–1987 (FinnTwin12, n=2578 pairs), aged 23.5–35.8 years
at the time of the study [15]. Altogether, of the 26MZ twin pairs
who were discordant for BMI (within-pair difference,
ΔBMI≥3 kg/m2, and reported previously [7, 16]); 14 healthy
pairs (three men, 11 women, aged 28.5±0.9 years) had adipo-
cytes available for the present study. Five healthy MZ twin pairs
concordant for BMI (ΔBMI<3 kg/m2, one man, four women,
aged 29.7±1.0 years) were included as controls. The mtDNA-
encoded transcript levels were determined from 12 discordant
twin pairs. The twins had no diseases and took no regular med-
ications except for contraceptives. In addition, six obese (mean
BMI 40±2.2 kg/m2; one man, five women, aged 49±2.8 years,
three on hypertensive medication) and seven lean (mean BMI
19.9±0.3 kg/m2; one man, six women, aged 31±1.5 years) in-
dividuals provided adipocytes for western blot analyses (see
electronic supplementary material [ESM] Methods). Written in-
formed consent was obtained from all participants. The study
protocol was designed and performed according to the principles
of the Helsinki Declaration and approved by the Ethical
Committee of the Helsinki University Central Hospital.
Clinical assessments and analytical measurements
Height and weight were measured, after participants had
fasted overnight, to calculate BMI. Body composition (dual-
energy x-ray absorptiometry) [17], volumes of SAT and vis-
ceral adipose tissue (VAT) (MRI), liver fat content (magnetic
resonance [MR] spectroscopy) [18] and plasma glucose and
insulin for calculation of HOMA and Matsuda indices, serum
high-sensitivity C-reactive protein (hs-CRP), plasma leptin,
adiponectin and physical activity were measured (see ESM
Methods), as previously described [19].
Adipose tissue biopsies, adipocyte extraction and RNA
extraction
Surgical biopsy samples of abdominal SAT were collected
under local anaesthesia and snap-frozen in −80°C liquid nitro-
gen. Adipocytes were collected by digesting a piece of fresh
adipose tissue in 2% collagenase–DMEM/F-12 (see ESM
Methods). Total adipose tissue and adipocyte RNA was ex-
tracted using RNeasy Lipid Tissue Mini Kit (Qiagen, Nordic,
Solletuna, Sweden) with a DNase I (Qiagen) digestion accord-
ing to the manufacturer’s instructions.
Part of the collagenase-digested adipose tissue sample was
used for measurement and calculation of adipocyte volume
and number (see ESM Methods) [19].
Transcriptomics and pathway analyses in adipocytes
and adipose tissue
Total RNA (500 ng) from adipocytes and adipose tissue was
used for gene expression analysis on an Affymetrix U133 Plus
2.0 array (Thermo Fischer, Santa Clara, CA, USA) according to
the manufacturer’s instructions. Pre-processing of the expres-
sion data was done with BioConductor software (open source,
www.bioconductor.org), the GC-RMA algorithm and annota-
tion by Brainarray CDF version 18 [20]. Differential expression
between the co-twins was analysed with Limma (a package of
Bioconductor, open source) [21], thereafter subjecting the sig-
nificant genes to Qiagen’s Ingenuity Pathway Analysis (IPA;
Qiagen Redwood City, www.qiagen.com/ingenuity, accessed 1
August 2015). The top ten significant pathways were chosen
for further examination and calculation of the mean centroid
values (indicating mean pathway activation of genes listed in
Table 4) [9]. Mean centroids were also calculated for the ex-
pression of small (MRPS, 29 transcripts in Affymetrix) and
large (MRPL, 49 transcripts) mitochondrial ribosomal proteins
(see our additional data on figshare https://dx.doi.org/10.6084
/m9.figshare.3806286.v1 data S1) [22]). MitoCarta [3], an
online atlas of 1013 nuclear and mtDNA genes encoding
proteins of mitochondrial localisation, was used to select
mitochondria-related transcripts among the significantly differ-
entially expressed genes between the co-twins.
Additionally, the significantly differentially expressed genes
between the co-twins that were consistently up- or downregu-
lated in the heavier co-twin, in at least 12 out of the 14 discor-
dant twin pairs, were analysed with IPA pathway analysis.
qRT-PCR of mtDNA-encoded transcripts and PGC-1α
in adipocytes
A total of 300 ng of RNA from adipocytes, synthesised to
complementary DNA (cDNA) (iScript cDNA Synthesis Kit,
170-8891; Bio-Rad, Hemel Hempstead UK), was used in the
quantitative reverse transcription PCR (qRT-PCR) analyses
(Bio-Rad) of mtDNA-encoded 12S rRNA (MT-RNR1), 16S
rRNA (MT-RNR2), mRNAs (MT-COX1, MT-ND5, MT-CYTB
and PGC-1α [also known as PPARGC1A]) (IQ Custom SYBR
Green Supermix 170-8860; Bio-Rad) [7] (see ESM Methods).
The nuclear-encoded 18S rRNA, GAPDH, YWHAZ and IPO8
genes were used as controls. The primer sequences are shown
in ESM Table 1. The data were analysed by qBASE+ (version
2.6.1, Biogazelle, Zwijnaarde, Belgium) software.
Western blot for OXPHOS protein levels in adipocytes
For the western blot, 10 μg of adipocyte protein lysates (ob-
tained by homogenisation in RIPA buffer) from six obese and
seven lean individuals was separated on 4–20% SDS-PAGE
gels. The primary antibodies were Total OXPHOS antibody
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mixture (110411; Abcam, Cambridge, UK); NDUFB8 (com-
plex I), SDHB (complex II), UQCRC2 (complex III), COX2
(complex IV) and ATP5A (complex V). Additionally, individ-
ual antibodies were used for complex III core 2 subunit
(MS304) and complex V subunit α (MS507). Actin (Santa
Cruz Biotechnology, Heidelberg, Germany), vinculin (Abcam
ab129002) and porin (Abcam) were used as controls. Total
OXPHOS and vinculin antibodies were incubated in 5% (wt/
vol.) milk/Tris-buffered saline (154 mmol/l NaCl) and 0.1%
(vol./vol.) Tween 20 (TBST) , and complex III-core 2 subunit,
complexV subunitα, actin and porin antibodies in 1% (wt/vol.)
BSA/TBST at concentrations of 1:1000 (vinculin at 1:10,000)
overnight at 4°C. Incubation with secondary horseradish
peroxidase-conjugated anti-mouse (Santa Cruz), anti-rabbit
(Jackson ImmunoResearch, Baltimore, NJ, USA) and anti-
goat (401504; Calbiochem, Darmstadt, Germany) (1:2500)
was carried out in 5% (wt/vol,) milk–TBST for 1 h at room
temperature (see ESM Methods). The proteins were quantified
with ImageLab v3.0 software (Bio-Rad, Hercules, CA, USA).
Statistical analyses
Statistical analyses were performed using Stata statistical soft-
ware (Release 13.0; Stata Corporation, College Station, TX,
USA). Differences between the co-twins were calculated by
Wilcoxon’s signed rank tests and differences in the protein
levels between lean and obese individuals by Mann–Whitney
U test. Correlations between pathways and anthropometric and
metabolic measures in all twin individuals were calculated
using Pearson correlations, corrected for clustered sampling
of co-twins by survey methods [23]. Non-normally distributed
variables (VAT, liver fat, adipocyte volume, HOMA index,
Matsuda, leptin, adiponectin and hs-CRP) were logarithmically
(base 10) corrected for analyses. Adjustments for multiple com-
parisons in Table 5 were made by the number of principal
components analysis (PCA) to provide a proper p value thresh-
old. The PCA correction for the mitochondrial variables pro-
duced two principal component factors, which explained 78%
of the variance. Therefore, the adjusted significance level for
analyses in Table 5 was p<0.05 divided by two (i.e. p<0.025).
For ESM Table 3 (adipose tissue) the analysis provided one
principal component explaining 81% of the variance, and an
adjusted p value of 0.05.
Results
The heavier (mean±SE BMI 29.9±1.0 kg/m2) and lighter
(24.1±0.9 kg/m2) co-twins of the discordant pairs had a mean
difference in body weight of 16.9 ± 1.8 kg (p < 0.001)
(Table 1). The heavier co-twins had more SAT, VAT and liver
fat, larger adipocytes and were more insulin resistant (p<0.05
all, Table 1). No significant differences in fat or metabolic
measures were found between the concordant co-twins, de-
spite a small difference in BMI (light 28.2 ± 1.9 vs heavy
30.4±1.8 kg/m2, p=0.043, Table 1).
Over 2000 genes were differentially expressed
in adipocytes within the discordant pairs, revealing
mitochondrial associations in pathway analyses
We first analysed the genome-wide differences in adipocytes
of the lighter vs heavier discordant co-twins. A total of 2538
transcripts (figshare data S2 [22]) were differentially
expressed within the twin pairs (nominal p value < 0.05).
The top ten up- and downregulated genes are presented ac-
cording to p value in Table 2 and fold change (FC) in Table 3,
and figshare data S2 [22].
The top ten pathways of the significantly differentially
expressed genes between the co-twins in adipocytes from IPA
analyses (all p<0.001) were subjected to calculation of themean
centroid values, representing the global transcriptional activity of
the pathway. Based on the mean centroids, the significantly
downregulated pathways in adipocytes of the heavier co-twins
were OXPHOS, glutaryl-CoA degradation, mTOR signalling
and branched-chain amino acid (BCAA) catabolism (valine
and isoleucine degradation) and the significantly upregulated
pathways were glucocorticoid receptor and IL-8 signalling
(p<0.05 all, Wilcoxon’s signed rank test, Table 4 and figshare
data S3 [22]). Mitochondria-related pathways of OXPHOS and
valine, isoleucine and glutaryl-CoA degradation correlated neg-
atively with many adiposity and insulin resistance measures and
hs-CRP, and positively with Matsuda index and adiponectin
(Table 5). For IL-8 receptor signalling and glucocorticoid recep-
tor signalling, the correlations were opposite to those seen for the
above mentioned mitochondrial pathways.
Upstream regulator analyses and reduced levels
of a major mitochondrial regulator PGC-1α in adipocytes
To detect transcripts regulating the observed genes and path-
ways, we performed an IPA upstream regulator analysis for the
significantly differentially expressed genes in adipocytes. The
top three significant regulators according to IPAwere SREBF1,
CEBPA and MYC (Table 6 and figshare S4 [22]). However, in
the subsequent Wilcoxon’s test of these transcripts, none were
significantly different between the co-twins.
When using the differentially expressed genes combined
with the MitoCarta gene list (figshare data S5 [22]) to detect
specifically mitochondria-related regulators, SREBF1, MYC
and PGC-1α (Table 6 and figshare data S6 [22]) emerged as
the top three regulators. PGC-1α was the only transcription
factor significantly reduced in the heavier compared with the
lighter co-twins (3.9±0.3 vs 4.3±0.3 Affymetrix units, respec-
tively, p=0.0157, Fig. 1a). This result was confirmed by qRT-
PCR (heavier 2.6±0.6 vs lighter 4.1±1.0, p=0.0414, Fig. 1b).
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Consistently up- and downregulated transcripts
in adipocytes revealed mitochondria-related
transcriptional downregulation and immune-related
upregulation
Next, we focused on the transcripts that were not only signif-
icantly different between the co-twins but also consistently
up- or downregulated in the heavier co-twins, in at least 12
out of 14 discordant twin pairs. Adipocytes had 454 consis-
tently upregulated and 538 consistently downregulated tran-
scripts in the heavier co-twins (figshare data S7 [22]). The
downregulated genes revealed mitochondria-related pathways
in IPA (OXPHOS, fatty acidβ-oxidation, AMP-activated pro-
tein kinase signalling, glutaryl-CoA degradation, tricarboxylic
acid [TCA] cycle; p<0.001 all), while the upregulated path-
ways displayed an immune-related pattern (IL-10 signalling,
granulocyte adhesion, IL-8 signalling, recognition of bacteria
and viruses, high mobility group box 1 (HMGB1) signalling
and cytokine production; p<0.001 all, figshare data S8 [22]).
Reduction of mtDNA transcript levels (qRT-PCR)
and mitochondrial ribosomal protein subunit gene
expression in the heavier co-twins’ adipocytes
The above results strongly suggest that genes targeting mito-
chondria are downregulated in the heavier co-twins’ adipo-
cytes. Because Affymetrix only captures nuclear genes, we
next analysed the expression of genes encoded by mtDNA
Table 1 Clinical characteristics of the MZ twins
Variable Weight-discordant pairs (ΔBMI ≥3 kg/m2) Weight-concordant pairs
(ΔBMI <3 kg/m2)
Lighter co-twin Heavier co-twin t test p value for lighter
vs heavier co-twins
Both co-twins
Weight (kg) 69.7 ± 4.1 86.6 ± 4.4 0.0010 80.5 ± 5.2
Height (cm) 169.4 ± 2.8 169.5 ± 2.8 0.6372 165.0 ± 2.2
BMI (kg/m2) 24.1 ± 0.9 29.9 ± 1.0 0.0010 29.3 ± 1.3
Body fat (%) 33.7 ± 1.7 42.0 ± 1.8 0.0015 36.3 ± 2.9
Fat (kg) 23.7 ± 1.9 35.9 ± 2.1 0.0010 29.7 ± 3.3
Fat-free mass (kg) 43.8 ± 2.7 48.1 ± 3.5 0.0012 48.4 ± 3.2
SAT (dm3) 3633.7 ± 324.7 6019.9 ± 426.4 0.0010 4494.6 ± 450.2
VAT (dm3) 814.3 ± 301.3 1503.7 ± 375.8 0.0015 868.2 ± 219.5
Liver fat (%) 0.85 ± 0.27 2.96± 0.81 0.0029 1.96 ± 0.92
Adipocyte volume (pl) 361.5 ± 47.3 530.4 ± 67.7 0.0012 417.4 ± 68.7
Adipocyte number (1013) 8.04 ± 0.76 8.20± 0.65 0.7299 8.72 ± 0.70
fP-glucose (mmol/l) 5.1 ± 0.1 5.1 ± 0.2 0.8337 5.3 ± 0.2
fP-insulin (pmol/l) 34.7 ± 4.2 57.6 ± 12.5 0.0277 43.8 ± 5.6
HOMA index 1.1 ± 0.2 2.0 ± 0.5 0.0231 1.5 ± 0.2
Matsuda index 8.0 ± 1.0 6.2 ± 0.8 0.0281 8.6 ± 1.5
AUC insulin in OGTT (pmol/l × h) 649.3 ± 81.9 1035.5 ± 320.2 0.0597 514.6 ± 101.4
Total cholesterol (mmol/l) 4.5 ± 0.2 4.8 ± 0.2 0.3428 4.6 ± 0.2
LDL-cholesterol (mmol/l) 2.6 ± 0.2 3.0 ± 0.2 0.0735 2.8 ± 0.2
HDL-cholesterol (mmol/l) 1.7 ± 0.1 1.5 ± 0.1 0.0120 1.3 ± 0.1
Triacylglycerol (mmol/l) 1.1 ± 0.1 1.4 ± 0.2 0.0843 1.1 ± 0.3
fP-Leptin (pg/ml) 18,801.7 ± 3896.5 35,070.7 ± 5447.7 0.0015 24,598.4 ± 6305.3
fP-Adiponectin (μg/ml) 3633.4 ± 338.5 2764.7 ± 331.1 0.0063 3329.2 ± 730.9
fS-hs-CRP (mmol/l) 29.5 ± 10.5 29.5 ± 8.6 0.8888 11.4 ± 2.9
Total physical activity (Baecke activity index) 8.3 ± 0.4 8.0 ± 0.3 0.5925 7.9 ± 0.7
Sport index (Baecke activity index) 2.8 ± 0.3 2.3 ± 0.2 0.1637 2.7 ± 0.4
Leisure index (Baecke activity-index) 3.0 ± 0.2 2.9 ± 0.1 0.9746 2.7 ± 0.2
Work index (Baecke activity-index) 2.6 ± 0.2 2.7 ± 0.2 0.5506 2.5 ± 0.2
Data are means ± SE (n=14 BMI-discordant pairs; n=5 BMI-concordant pairs)
Wilcoxon’s rank sum test was used to compare values of the lighter vs the heavier co-twin
fP, fasting plasma; fS, fasting serum. Total physical activity and its sub-compartments (sport-, leisure- and work-indices) were calculated using the
Baecke index (see ESM Methods)
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by qRT-PCR. Here, the mitochondrial rRNAs (12S,
MT-RNR1, p=0.0022 and 16S, MT-RNR2, p=0.0186) and
mRNAs (MT-COX1, CIV subunit, p=0.0047, MT-ND5, CI
subunit, p=0.0186, and MT-CYTB, CIII subunit, p=0.0047)
were significantly downregulated in the heavier as compared
with the lighter co-twins (Fig. 2).
The mitochondrial rRNAs and mRNAs are translated
into proteins by mitochondrial ribosomes. The mean cen-
troids of both small (−0.24±0.18 vs 0.23±0.18 arbitrary
Affymetrix units [AU], p=0.0092) and large (−0.17±0.18
vs 0.18 ± 0.17 AU, p=0.0157) mitochondrial ribosomal
protein subunit transcripts were downregulated in the
heavier compared with the lighter co-twins’ adipocytes
(Fig. 3 and figshare data S1 [22]).
Reduction of OXPHOS protein levels in adipocytes
of obese vs lean individuals
The mitochondrial OXPHOS protein CI subunit NDUFB8
(p=0.0176) and CIII-core 2 subunit (CIII, p=0.0455) were
significantly reduced in the obese compared with the lean in-
dividuals, whereas COX2 (CIV subunit, p=0.253), ATP5A
(CV subunit, p=0.254) and the nuclear-encoded CII subunit
SDHB (p=0.361) were not (Fig. 4). When the OXPHOS pro-
tein signals were normalised against the mitochondrial protein
porin, complex CI subunit NDUFB8 (p=0.0106) was signifi-
cantly reduced in the obese compared with the lean individ-
uals, suggesting a possible decrease in OXPHOS CI levels per
mitochondria. CIV levels decreased non-significantly
Table 2 Top up- and downregulated genes in adipocytes of the heavier vs lighter co-twins (n=14 discordant pairs) according to significance in adjusted
p values
Symbol Description Function (NCBI gene and Uniprot
databases)
Adjusted p value FC
Upregulated genes
TNFRSF10A TNF receptor superfamily, member 10a Caspase-mediated apoptosis. NF-kB activation 0.0056 1.51
VGLL3 Vestigial-like family member 3 Coactivator for mammalian TEFs 0.0182 1.50
PAG1 Phosphoprotein associated with
glycosphingolipid microdomains 1
Regulation of T cell activation, cell adhesion 0.0246 1.41
LOC100132891 Uncharacterised LOC100132891 Uncharacterised 0.0263 1.71
PHLDA2 Pleckstrin homology-like domain, family
A, member 2
Regulation of placenta growth, role in
membrane lipid binding
0.0393 2.11
HIATL1 Hippocampus abundant transcript-like 1 – 0.0394 1.32
ITGAV Integrin, αV Cell surface adhesion, signalling, angiogenesis 0.0394 1.15
PLEKHA1 Pleckstrin homology domain containing,
family A (phosphoinositide binding
specific) member 1
Binds to PI(3,4)P2 may recruit proteins to
plasma membrane
0.0439 1.23
FILIP1L Filamin A interacting protein 1-like Regulator of the antiangiogenic activity on
endothelial cells
0.0446 1.36
FAM177A1 Family with sequence similarity 177,
member A1
– 0.0484 1.28
Downregulated genes
C11orf31 Chromosome 11 open reading
frame 31
Redox-related processes, inhibition of apoptotic
cell death pathways, promotion of
mitochondrial biogenesis
0.0236 0.90
ATP5L ATP synthase, H+ transporting,
mitochondrial F0 complex, subunit G
Catalyses ATP synthesis, part of the complex V
F0 domain
0.0263 0.91
CKB Creatine kinase, brain Energy homeostasis, catalyses the transfer of
phosphate between ATP and phosphogens
0.0263 0.68
ORMDL3 ORM1-like 3 (Saccharomyces
cerevisiae)
Negative regulator of sphingolipid biosynthesis 0.0359 0.62
BIN3 Bridging integrator 3 Endocytosis, intracellular transport, cytokinesis 0.0394 0.81
PDK2 Pyruvate dehydrogenase kinase,
isozyme 2
Regulation of glucose and fatty acid metabolism,
downregulation of aerobic respiration,
maintenance of blood glucose levels
0.0394 0.68
NDUFB8 NADH dehydrogenase (ubiquinone)
1β subcomplex, 8, 19 kDa
Subunit of the mitochondrial respiratory complex I 0.0484 0.89
ACSS3 Acyl-CoA synthetase short-chain family
member 3
Activates acetate for use in lipid synthesis or
energy generation
0.0484 0.71
GSDMB Gasdermin B Regulation of apoptosis, mediates pyroptosis 0.0484 0.56
PI(3,4)P2, phosphatidylinositol 3,4-diphosphate; TEF, transcription enhancer factor
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(p = 0.088) and CII (p = 0.988), CIII (p = 0.199) and CV
(p=0.775) levels were unchanged (Fig. 4).
Adipocyte volume and number
Whether adipocyte size matters in reduced mitochondrial bio-
genesis or the metabolic complications in obesity is debatable,
so we analysed the associations of adipocyte size and number
with the above gene expression results. Adipocyte volume
was significantly larger in the heavier than in the lighter co-
twins, while the number of adipocytes did not differ between
the co-twins (Table 1). Adipocyte volume correlated
negatively with mitochondrial glutaryl-CoA degradation and
mTOR signalling and positively with inflammatory IL-8
signalling for adipocytes (Table 5). However, in a multiple
regression analysis adjusting for body fat mass (kg) and sex,
adipocyte volume did not yield independent associations with
the gene expression pathways (data not shown).
Adipose tissue transcriptomic analyses mimicked those
of the adipocytes
To compare the gene expression results from adipocytes with
those from adipose tissue, we performed the same
Table 3 Top up- and downregulated genes in adipocytes of the heavier compared with the lighter co-twins (n=14 discordant pairs) according to largest
FC
Symbol Description Function (NCBI gene and Uniprot databases) Nominal p value FC
Upregulated genes
EGF6 EGF-like-domain, multiple 6 Mitogenic factor, growth, proliferation and
differentiation
0.0010 5.66
VSIG4 V-set and immunoglobulin domain
containing 4
Phagocytic receptor, strong gulator of T cell
proliferation and IL2 production
0.0011 3.48
EVI2A Ecotropic viral integration site 2A Potential cell surface receptor 0.0004 2.75
EREG Epiregulin Contributes to inflammation, regulation of
angiogenesis and cell proliferation
0.0285 2.74
IFI30 IFNγ-inducible protein 30 Antigen processing 0.0216 2.65
CD163 CD163 molecule Inflammation-related 0.0019 2.64
GPR183 G protein-coupled receptor 183 Receptor for oxysterols, function in innate
immune response
0.0060 2.53
MIR155HG MIR155 host gene (non-protein coding) miRNA 0.0105 2.50
IL1A IL-1α Immune responses, inflammatory processes
and haematopoiesis
0.0125 2.47
CCL13 Chemokine (C-C motif) ligand 13 Chemotactic factor, attraction of leucocytes
in inflammation
0.0003 2.45
TNF TNF Proinflammatory cytokine; cell proliferation,
differentiation, apoptosis, lipid metabolism,
and coagulation
0.0151 2.43
FCGR2B Fc fragment of IgG, low affinity IIb,
receptor (CD32)
Phagocytosis of immune complexes and the
regulation of antibody production
0.0023 2.43
Downregulated genes
SLC27A2 Solute carrier family 27 (fatty acid
transporter), member 2
Acyl-CoA synthetase, lipid biosynthesis and
fatty acid degradation
0.0005 0.25
C12orf39 Chromosome 12 open reading frame 39 Energy metabolism and storage; in rats has
been shown to cause weight loss
0.0001 0.28
KCNK6 Potassium channel, subfamily K, member 6 Potassium channel protein 0.0077 0.29
CA3 Carbonic anhydrase III, muscle specific Reversible hydration of carbon dioxide 0.0001 0.31
AGPAT9 1-Acylglycerol-3-phosphate O-acyltransferase 9 Conversion of glycerol-3-phosphate to
lysophosphatidic acid in the synthesis of
triacylglycerol
0.0024 0.35
CISH Cytokine inducible SH2-containing protein Suppressor of cytokine signalling 0.0001 0.35
NWD2 NACHT and WD repeat domain containing 2 – 0.0247 0.39
AZGP1 α-2-Glycoprotein 1, zinc-binding Stimulates lipid degradation in adipocytes 0.0002 0.41
NAALAD2 N-Acetylated α-linked acidic dipeptidase 2 Cleaves NAG 0.0001 0.43
CASQ2 Calsequestrin 2 (cardiac muscle) Release of luminal Ca2+ via the calcium release
channel
0.0012 0.44
NAG, N-acetyl-L-aspartate-L-glutamate
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transcriptional analyses of the 14 discordant co-twins in adi-
pose tissue. A total of 2135 transcripts (figshare data S2 [22])
were differentially expressed between the co-twins (nominal p
value < 0.05). As in adipocytes, the top ten upregulated genes
in the heavier co-twins were associatedwith immune reactions
and the top ten downregulated transcripts (figshare data S2
[22]) were associated with mitochondria, fatty acid synthesis
and β-oxidation. Analyses according to the largest FC
Table 4 Top ten pathways in adipocytes of the heavier compared with the lighter co-twins (IPA analysis of the significantly differentially expressed
genes, n=14 discordant twin pairs)
Ingenuity canonical pathway IPA p valuea Wilcoxon
p valueb
Regulationc Gene
OXPHOS <0.001 0.0019 Downregulated NDUFA4, SDHB, NDUFA7, COX6C, COX10, COX5B, COX8A,
NDUFB5, ATP5L, NDUFB8, ATP5G2, ATP5S, NDUFA1,
NDUFA2, NDUFB10, NDUFB9, NDUFAB1, ATPAF1,
NDUFS2, ATP5I, ATP5F1, COX4I1, NDUFS4, NDUFA8,
COX6B1, NDUFB4, ATP5O, NDUFS7, ATP5A1, NDUFV3,
SURF1, COX7C, NDUFS3, UQCRB, ATP5C1, NDUFB11,
ATP5B, NDUFA6, UQCR10, UQCRC2, CYC1, COX5A,
COX7A2, NDUFA12, CYB5A, UQCRC1
Valine degradation I <0.001 0.0035 Downregulated HADHB, BCAT1, ECHS1, BCAT2, ABAT, HIBADH, BCKDHA,
ACAD8, ALDH6A1, HADHA, BCKDHB
Glucocorticoid receptor
signalling
<0.001 0.0029 Upregulated YWHAH, MAPK1, SGK1, HSPA1A/HSPA1B, PBX1, KRAS,
CD163, HSPA5, TAF13, TSC22D3, TGFBR2, CXCL3, IKBKB,
PPP3R1, SERPINE1, POLR2I, CXCL8, STAT5A, SELE,
CDKN1C, RAC1, POLR2K, GTF2F1, STAT3, PCK1, NCOA3,
IL1RN, MAPK10, TNF, UBE2I, POLR2B, NR3C1, PTGES3,
PRKAG1, BCL2, HSP90B1, JUN, CCL13, KAT2B, POLR2C,
ANXA1, FOXO3, GTF2H5, CHUK, STAT1, MAP2K1,
PPP3CA, AGT, ADRB2, MAP2K7, NRAS, IL10, GRB2, CHP1,
CEBPB, TSG101, GTF2E1, NFATC2, IL1B, NRIP1, PLAU,
HLTF
IL-8 signalling <0.001 0.0012 Upregulated ANGPT2, MAPK1, GNB2L1, KRAS, IQGAP1, CCND1, PDGFC,
GNG7, BCL2, EIF4EBP1, IRAK1, BRAF, GNB1, VEGFA,
IKBKB, HMOX1, JUN, RHOB, GPLD1, CYBB, ITGAV, CXCL1,
GNA13, CHUK, MAP2K1, VASP, ITGB5, GNG12, LASP1,
CXCL8, GNAS, NRAS, GNA12, GNG2, RAC1, IRAK3, PLD1,
ITGB2, CCND2, ITGAM, RHOQ, RHOA, NCF2, MAPK10,
MAP4K4, FNBP1, IRAK4, MMP9
mTOR signalling <0.001 0.0043 Downregulated TSC1, ULK1,MAPK1, RPS6KA3, KRAS, EIF4A2, PDGFC, RPS11,
PRKAG1, EIF4E, EIF4EBP1, VEGFA, HMOX1, RHOB,
RPS20, EIF4G2, EIF3B, GPLD1, TSC2, PPM1L, PPP2R5C,
AKT1S1, RPS24, MAPKAP1, NRAS, EIF3H, PPP2R5D, RAC1,
PLD1, EIF3M, RPS6, EIF3G, FAU, PPP2R1A, RHOQ, IRS1,
RHOA, RPS27L, EIF3I, INSR, FNBP1, EIF3L, RPS14, EIF3K
Role of JAK2 in hormone-
like cytokine signalling
<0.001 0.9750 Not changed STAT5A, SOCS1, PTPN6, GHR, PTPN11, SH2B3, IRS1, IRS2,
STAT3, STAT1, SOCS5, HLTF, SH2B1
Isoleucine degradation I <0.001 0.0012 Downregulated HSD17B10, HADHB, BCAT1, ECHS1, BCAT2, ACAD8, ACAT1,
HADHA
Glutaryl-CoA degradation <0.001 0.0012 Downregulated HSD17B10, HADHB, ACAT1, HADHA, HADH, GCDH,
HSD17B8
NRF2-mediated oxidative
stress response
<0.001 0.0736 Not changed FTL, GSTM5, MAPK1, DNAJB4, PRDX1, DNAJA4, HSPB8,
DNAJC3, KRAS, DNAJC10, DNAJB2, MAP3K5, CLPP, MAFG,
HMOX1, JUN, ABCC1, GSTM4, UBE2K, DNAJA3, JUND,
TXN, DNAJB1, NFE2L2, MAP2K1, CBR1, UBB, MAP2K7,
DNAJB12, NRAS, GSTM3, NQO1, DNAJC19, JUNB, MAFF,
TXNRD1, DNAJC11, MGST2, DNAJB11, DNAJB6, MAP2K5,
FTH1
a IPA-predicted p value on the enrichment of significantly differentially expressed genes to a certain pathway and its predicted activation
b The t test p value from the Wilcoxon signed rank test to determine whether the pathway activation is different between the co-twins according to the
calculated mean centroid values for pathway activation
c Pathway up- or downregulation based on mean centroid value comparisons between the co-twins
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between the co-twins revealed chemokines and inflammatory
genes among the top upregulated list, as in adipocytes.
Downregulated transcripts included mostly the same genes
as in adipocytes.
The pathway analyses in adipose tissue mimicked those of
adipocytes, with OXPHOS, valine and lysine degradation,
glutaryl-CoA degradation, acetate conversion to acetyl-CoA,
fatty acidβ-oxidation, triacylglycerol synthesis and ketone body
production and breakdown among the top ten pathways; the
mean centroids of these were all downregulated in the heavier
co-twins (p<0.05 all,Wilcoxon’s signed rank test, ESMTable 2
and figshare data S3 [22]). In general, significant negative
correlations were found for the mean centroids of the top ten
pathways and adiposity, including adipocyte size, leptin, insulin
resistance and hs-CRP and positive correlations with Matsuda
index and adiponectin (ESM Table 3). Triacylglycerol synthesis
correlated only with VAT and liver fat.
The top three upstream regulators in adipose tissue were
BACH1, CEBPA and ERG, the mean centroids of which did
not differ between the co-twins. When combining the gene list
withMitoCarta (figshare data S5 [22]) to analyse the mitochon-
drial upstream regulators in adipose tissue, SREBF1, PGC-1α
and EIF2A (figshare data S6 [22]) emerged as the top three
regulators. PGC-1α (3.8 ± 0.3 vs 4.9 ± 0.3 AU, p=0.0019
ESM Fig. 1a) and EIF2A (11.2 ± 0.04 vs 11.4 ± 0.1 AU,
p=0.0029) were downregulated in the heavier co-twins.
In consistency analyses we found 221 upregulated and 437
downregulated transcripts (figshare data S7 [22]) in the
Table 5 Correlations of the transcriptomic pathways in adipocytes with metabolic measures in individual MZ twins (n= 38)
Pathway Fat kg SAT VAT Liver fat Adipocyte volume HOMA Matsuda Leptin Adiponectin hs-CRP
OXPHOS −0.51* −0.42 −0.70*** −0.55** −0.51 −0.51 0.61** −0.24 0.48*** −0.41
Valine degradation −0.56** −0.48* −0.66*** −0.61*** −0.57 −0.54** 0.68*** −0.38 0.50* −0.46*
Glucocorticoid receptor
signalling
0.48* 0.44 0.67*** 0.58** 0.42 0.37 −0.61** 0.31 −0.49** 0.49*
IL-8 signalling 0.64*** 0.61** 0.84*** 0.64*** 0.59* 0.54** −0.70*** 0.40* −0.44** 0.57**
mTOR signalling −0.39* −0.42** −0.46** −0.41* −0.51** −0.32 0.39* −0.31** 0.14 −0.28
Role of JAK2 in
hormone-like
cytokine signalling
0.33 0.25 0.16 0.25 0.32 −0.01 −0.12 0.24 −0.04 0.26
Isoleucine degradation I −0.55** −0.43 −0.62** −0.62** −0.55 −0.52** 0.65*** −0.35 0.56** −0.46
Glutaryl-CoA degradation −0.62** −0.54** −0.72*** −0.65*** −0.66** −0.55** 0.70*** −0.44* 0.50** −0.47
NRF2-mediated oxidative
stress response
0.23 0.18 0.25 0.09 0.11 0.16 −0.20 0.13 −0.43** 0.09
Regulation of eIF4 and
p70S6K signalling
−0.37 −0.38 −0.44 −0.39 −0.46 −0.36 0.35 −0.20 0.07 −0.18
Data show Pearson correlations, multiple-corrected by mitochondrial variables by PCA (number of principal components) method
*p< 0.025, **p< 0.01 and ***p < 0.001
JAK2, Janus kinase 2; NRF2, Nuclear factor, erythroid 2 like 2
Table 6 Top upstream regulators of the significantly changed tran-
scripts between the co-twins in adipocytes and mitochondria-related top
upstream regulators of significantly changed transcripts between the co-
twins in adipocytes
Regulator p value
(IPA-predicted)
Change between the co-twins
(t test, Affymetrix expression levels)
Upstream regulators in adipocytes
SREBF1 <0.001 Not changed between the co-twins
CEBPA <0.001 Not changed between the co-twins
MYC <0.001 Not changed between the co-twins
TP53 <0.001 Not changed between the co-twins
Mitochondria-related upstream regulators
SREBF1 <0.001 Not changed between the co-twins
MYC <0.001 Not changed between the co-twins
PPARGC1A <0.001 Downregulated in the heavier co-twin
MYBL1 <0.001 Not changed between the co-twins
Fig. 1 Reduced levels of mitochondrial regulator, PGC-1α, in adipo-
cytes of the heavier co-twins. (a) Affymetrix expression. (b) qRT-PCR,
n=14 discordant co-twins; 18S RNA, hGAPDH, YWHAZ and IPO8 as
control genes. White bars, lighter twins; black bars, heavier twins.
Wilcoxon’s rank sum test, *p< 0.05 vs the lighter twins. Data is presented
as mean ± SEM
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heavier co-twins’ adipose tissue. The top significantly down-
regulated pathways included, for example, cell cycle control,
DNA modifications, mTOR signalling and cholesterol bio-
synthesis, and upregulated pathways mostly immune- and
lipid-related signalling (p<0.001 all, IPA, figshare data S8
[22]).
In our previous study with 26 BMI-discordant pairs [7], we
reported reduced expression of mitochondrial ribosomal pro-
tein subunit transcripts in the heavier co-twins’ adipose tissue.
In the current study, we repeated these ribosomal protein sub-
unit expression level analyses in adipose tissue in the 14 dis-
cordant pairs. BothMRPS (heavier twins −0.24±0.19 vs ligh-
ter twins 0.11±0.14 AU, p<0.01) and MRPL (heavier twins
−0.21±0.2 vs lighter twins 0.01±0.15 AU, p<0.05, figshare
data S1 [22]) were downregulated in the heavier co-twins
(ESM Fig. 1b), as in adipocytes.
Discussion
This study of BMI-discordant MZ twin pairs shows that
mitochondria-related transcriptional signature, at the nuclear
and mitochondrial transcription level, is downregulated in ad-
ipocytes in the heavier co-twins. This was particularly the case
in the consistency analyses: the genes that were consistently
downregulated in at least 12 out of the 14 heavier co-twins
were involved in mitochondrial pathways. Subsequently, ex-
pression results of PGC-1α, the major regulator of mitochon-
drial biogenesis, the mtDNA-encoded genes and the mito-
chondrial ribosomes as well as reduced levels of OXPHOS
CI and CIII subunits all demonstrated that mitochondrial ox-
idative metabolism is downregulated in adipocytes of individ-
uals with higher body weight. Thus, we suggest that adipo-
cytes are major contributors to the downregulation of mito-
chondrial oxidative pathways and reduction in OXPHOS pro-
tein levels in obese adipose tissue. The most consistently up-
regulated genes in the heavier co-twins’ adipocytes clustered
to inflammatory pathways suggesting that inflammatory sig-
nature arises also from purified adipocytes. Simultaneous sup-
pression of mitochondria and activation of inflammatory gene
expression suggests that these two phenomena may be biolog-
ically linked.
Our study reports similarities in the gene expression pat-
terns of subcutaneous adipocytes and SAT in the BMI-
discordant twin pairs. Notably, genes clustering to mitochon-
drial pathways were the most significantly downregulated in
the heavier co-twins both in adipocytes and in adipose tissue.
We have previously demonstrated a widespread downregula-
tion of mitochondria- and nuclear-encoded mitochondria-re-
lated genes, reduction of mtDNA amount and reduction of
OXPHOS protein subunit levels in adipose tissue of heavier
vs leaner co-twins [7]—alterations that were associated with
fatty liver, insulin resistance and low-grade inflammation [7,
16].We have also shown reduced expression of mitochondrial
pathways and upregulated inflammatory pathways in adipose
tissue in obesity [9]. Other studies have also reported down-
regulation of mitochondrial oxidative metabolism in obesity.
Oxidative capacity was lower in adipose tissue of obese mice
compared with lean mice [24, 25] and in humans, membrane
potential, the activity of the respiratory chain complexes I–IV
and phosphate utilisation were reduced in isolated mitochon-
dria from obese SAT [26]. The studies on adipose tissue, how-
ever, include SVFCs that contribute to the results. In recent
studies in adipocytes, the oxygen consumption rates [12] and
subunit levels of complexes I and IV [13] were lower in obese
vs lean individuals. In contrast, Dahlman et al suggested that
the downregulation of electron transport chain genes in VAT
of women with type 2 diabetes would be independent of obe-
sity [27]. In our study we had the opportunity to compare gene
expression of subcutaneous adipocytes and SAT in MZ dis-
cordant co-twins and examine the effects of acquired excess
weight. Our results show that both adipocytes and adipose
tissue are remarkably similar regarding the expression and
downregulation of mitochondria-related genes and pathways
in the heavier co-twins, suggesting that adipocytes seem to be
a major contributor to the reduced mitochondrial oxidative
metabolism of adipose tissue in acquired obesity.
Fig. 2 Reduced levels of mitochondrial mtDNA transcripts (qRT-PCR;
rRNA’s 12S RNA, 16S RNA and mRNA’s MT-COX1, MT-ND5, MT-
CYTB) in the heavier co-twins’ adipocytes (n=12 discordant co-twins);
18S RNA, hGAPDH, YWHAZ and IPO8 as control genes. White bars,
lighter twins; black bars, heavier twins. Wilcoxon’s rank sum test,
*p < 0.05 and **p < 0.01 vs lighter twins. Data is presented as mean
± SEM
Fig. 3 Reduced levels ofMRPS andMRPL transcripts in the heavier co-
twins’ adipocytes (n=14 discordant co-twins). White bars, lighter twins;
black bars, heavier twins. Wilcoxon’s rank sum test, *p < 0.05 and
**p< 0.01 vs lighter twins. Data is presented as mean± SEM
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Strongly upregulated inflammatory gene expression was
found in adipocytes and adipose tissue of the heavier co-twins.
Adipose tissue of obese persons is characterised by accumu-
lation of macrophages and other immune cells [28, 29].
Inflammatory cells release inflammatory cytokines in obese
adipose tissue [28, 30, 31]. However, adipocytes are also
known secretors of IL-6, IL-8, TNF-α and inflammatory
adipokines [32], and exhibit immune-cell-like functions that
trigger CD4+ T cell inflammation, independent of macro-
phages [33]. Macrophage-derived TNF-α enhances the ex-
pression of inflammatory genes in murine adipocytes [34,
35]. In humans, adipose tissue TNF-α expression and secre-
tion is increased in obesity [36, 37] and may mediate insulin
resistance [36, 38]. However not all studies agree [37, 39].
Adipocytes also express high levels of CD14 and CD68
[40], previously considered as being macrophage-specific.
The upregulation of inflammatory genes and pathways in the
heavier co-twins in our study supports findings that adipo-
cytes do contribute to the amplified inflammatory milieu of
obese adipose tissue, even though inflammation in the whole
adipose tissue most probably arises also from the SVFCs.
In our study, we report the associations of mitochondrial
downregulation in adipocytes and adipose tissue with in-
creased adiposity (subcutaneous, visceral, liver fat) and im-
paired metabolism (reduced insulin sensitivity, plasma
adiponectin and increased hs-CRP levels). However, the di-
rection of causality between mitochondrial downregulation
and metabolic impairments is not clear. In fat-specific Tfam-
knockout mice, increased mitochondrial oxidation protected
from the development of diet-induced obesity, hepatosteatosis
and insulin resistance [41]. In contrast, studies in high-fat-fed
mice have suggested that reduction in adipose tissue mito-
chondrial content occurs after the development of impaired
glucose homeostasis [42, 43]. In a murine model of obesity,
however, mitochondrial respiratory capacity in adipocytes
was reduced irrespective of the glucose tolerance status
[44]. In humans, genes related to mitochondrial oxidative
metabolism at the transcription level have been shown to be
downregulated in type 2 diabetes and in the VAT but not SAT
depots [27].
In our study, adipocyte volume had significant negative
correlations with mitochondrial pathways in adipocytes and
adipose tissue. Enlargement of adipocytes is a main feature in
obesity [45, 46]. Failure of adipocyte differentiation and pre-
adipocyte recruitment is thought to result in excess adipocyte
hypertrophy and in insulin-resistant adipocytes [47, 48]. This
could lead tometabolic problems [19] and could be a means of
distinguishing between metabolically unhealthy and healthy
obese individuals [16]. However, after adjusting for body fat
mass (kg) and sex, mitochondrial pathways and adipocyte size
were not correlated in our study, indicating that reduction in
mitochondrial transcription was due to general fat accumula-
tion rather than cell size. Some recent studies also supported
this view by showing that adipocyte mitochondrial respiration
is reduced in human obesity independent of adipocyte size
[12, 13] and demonstrated that the compromised respiratory
capacity may be a general feature of all adipocytes from an
obese individual, not only of the enlarged adipocytes [13].
Studies in unrelated individuals raise the question of
whether adipocytes from obese individuals are genetically
equipped with poor mitochondria or whether this is an ac-
quired phenomenon. The MZ co-twin setting gives a unique
opportunity to control for genetic and early environmental
factors. In our data, the reduced mitochondria-related tran-
scription in obese adipocytes is clearly acquired. However,
because our study is cross-sectional, we cannot make defini-
tive cause-and-effect conclusions. Since the BMI discordance
in our twins only became evident in young adulthood [7, 49],
it is likely that the adipocyte mitochondria within the twin
pairs were similar until that period of life. Because we were
not able tomeasure the mitochondrial pathways of SVFCs, we
cannot make conclusions on how strong the influence of adi-
pocytes is on mitochondria-related transcriptional downregu-
lation in relation to SVF cells of adipose tissue. In the absence
of the measures of mitochondrial function, mRNA measures
alone do not provide direct evidence of the physiological dys-
function of mitochondria. The low level of significantly dif-
ferent transcripts, corrected for false-discover rate, between
the co-twins in the adipocyte transcriptomics data may be
related to the small number of twin pairs in the study. The
Fig. 4 Reduced levels of OXPHOS protein subunits CI–CV (a) per cell
(compared with cytosolic actin) and (b) per mitochondria (compared with
mitochondrial porin) in the obese (n=6, black bars) compared with the
lean (n=7, white bars) individuals. Wilcoxon’s rank sum test, *p < 0.05,
†p = 0.08 vs lean individuals. Data is presented as mean ± SEM
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studied twin pairs were also healthier than the other 12 twin
pairs included in our previous analyses [7]. Although we saw
clear trends for lower protein levels in the obese individuals, in
most cases the statistical power was too low to detect signif-
icant p values. The lean and obese unrelated individuals had
larger differences related to age and BMI compared with the
twins. Due to limited sample material, the mtDNA amount
could not be measured. Because of the small sample size
and the associative nature of the study, the results may need
to be confirmed with larger data.
In this study we demonstrate for the first time that gene
expression differences in acquired obesity are similar in adi-
pocytes and adipose tissue of young MZ BMI-discordant co-
twins. Mitochondria-related nuclear pathways and transcripts
were downregulated in adipocytes and adipose tissue, and
mtDNA transcript levels and levels of CI and CIII OXPHOS
subunits reduced in adipocytes, from individuals with larger
body weight. Our results suggest that downregulation of the
essential functions of mitochondria, such as OXPHOS,
BCAA catabolism, TCA cycle, fatty acid β-oxidation and
ketone metabolism, as well as upregulation of inflammation,
are key characteristics of adipocytes in obesity.
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